Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer Lili X. WangMark Agulnik Leading Article 12 September 2012 Pages: 1609 - 1619
Managing the Patient with Co-Morbid Depression and an Anxiety Disorder Robert A. SchoeversHenricus L. VanJack J. Dekker Therapy in Practice 12 September 2012 Pages: 1621 - 1634
Endothelin Receptor Antagonism Peter KabungaGerry Coghlan Review Article 12 September 2012 Pages: 1635 - 1645
Platelet Activation, and Antiplatelet Targets and Agents Yao-Zu XiangYe XiaBo-Li Zhang Review Article 12 September 2012 Pages: 1647 - 1664
An Evaluation of Eptacog Alfa in Nonhaemophiliac Conditions Gordon MallarkeyTim BrightonMadien Gazarian Review Article 12 September 2012 Pages: 1665 - 1689
Dabigatran Etexilate Mark SanfordGreg L. Plosker Adis Drug Profile 12 September 2012 Pages: 1699 - 1709
Fentanyl Transdermal Matrix Patch (Durotep® MT Patch; Durogesic® DTrans®; Durogesic® SMAT) Sheridan M. HoyGillian M. Keating Adis Drug Profile 12 September 2012 Pages: 1711 - 1721
Mometasone Furoate Claudine M. BaldwinLesley J. Scott Adis Drug Evaluation 12 September 2012 Pages: 1723 - 1739